Literature DB >> 24982408

Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancer.

Kiichiroh Nakano1, Mitsuchika Hosoda2, Mitsugu Yamamoto2, Hiroko Yamashita2.   

Abstract

BACKGROUND: The neutrophil:lymphocyte ratio (NLR) has been reported to reflect systemic inflammation and to have independent prognostic value for patients with various cancers. In this study, we analyzed the association between NLR and clinicopathological factors and verified the significance of NLR as a prognostic factor for Japanese patients with breast cancer. PATIENTS AND METHODS: A total of 167 Japanese female patients with stage I-III breast cancer were retrospectively recruited into this study. Associations with clinicopathological factors and NLR were assessed, and disease-free survival and breast cancer-specific survival were estimated.
RESULTS: In multivariate analysis, lymph node metastases and NLR were significantly associated with disease-free survival and breast cancer-specific survival. NLR was significantly higher in patients with lower body-mass index.
CONCLUSION: Preoperative NLR may be an independent prognostic factor for survival in Japanese patients with breast cancer. Reduction of body mass index has been implicated in NLR elevation, particularly in postmenopausal women. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Breast cancer; body-mass index; neutrophil:lymphocyte ratio

Mesh:

Year:  2014        PMID: 24982408

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  19 in total

1.  Relationship Between FDG Uptake and the Platelet/lymphocyte Ratio in Patients With Breast Invasive Ductal Cancer.

Authors:  Takaaki Fujii; Shoko Tokuda; Yuko Nakazawa; Sasagu Kurozumi; Sayaka Obayashi; Reina Yajima; Ken Shirabe
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.

Authors:  Derya Kivrak Salim; Hasan Mutlu; Melek Karakurt Eryilmaz; Ozan Salim; Fatma Yalçin Musri; Deniz Tural; Şeyda Gündüz; Hasan Şenol Coşkun
Journal:  Mol Clin Oncol       Date:  2015-05-04

3.  Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients.

Authors:  B Losada; J A Guerra; D Malón; C Jara; L Rodriguez; S Del Barco
Journal:  Clin Transl Oncol       Date:  2018-11-30       Impact factor: 3.405

4.  The neutrophil-lymphocyte ratio as an inflammatory marker in acute exacerbation of COPD.

Authors:  Raim Iliaz; Sinem Iliaz
Journal:  Wien Klin Wochenschr       Date:  2016-07-05       Impact factor: 1.704

5.  Prediction of outcome in breast cancer patients using test parameters from complete blood count.

Authors:  Pingping Zhang; Yulong Zong; Mohan Liu; Yanhong Tai; Yuan Cao; Chengiin Hu
Journal:  Mol Clin Oncol       Date:  2016-03-22

6.  Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.

Authors:  Jie Chen; Qiwen Deng; Yuqin Pan; Bangshun He; Houqun Ying; Huiling Sun; Xian Liu; Shukui Wang
Journal:  FEBS Open Bio       Date:  2015-05-12       Impact factor: 2.693

7.  Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer.

Authors:  C-H Koh; N Bhoo-Pathy; K-L Ng; R S Jabir; G-H Tan; M-H See; S Jamaris; N A Taib
Journal:  Br J Cancer       Date:  2015-05-28       Impact factor: 7.640

8.  Predictive contribution of neutrophil/lymphocyte ratio in diagnosis of brucellosis.

Authors:  Serdar Olt; Hasan Ergenç; Seyyid Bilal Açıkgöz
Journal:  Biomed Res Int       Date:  2015-02-03       Impact factor: 3.411

9.  Prognostic significance of platelet-lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer.

Authors:  Tae Ju Park; Yang Hyun Cho; Ho Seok Chung; Eu Chang Hwang; Sung-Hoon Jung; Jun Eul Hwang; Woo Kyun Bae; Jin Woong Kim; Suk Hee Heo; Young Hoe Hur; Seung Il Jung; Dong Deuk Kwon
Journal:  Springerplus       Date:  2016-10-28

10.  The Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer.

Authors:  Joseph Rimando; Jeff Campbell; Jae Hee Kim; Shou-Ching Tang; Sangmi Kim
Journal:  Front Oncol       Date:  2016-03-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.